EBV Strategies to Counteract the Immune Response

11k
Total downloads
70k
Total views and downloads

Articles

CASE REPORT

Published on 11 Nov 2025

Hemophagocytic lymphohistiocytosis as the initial manifestation of Epstein–Barr virus-related T/NK-cell lymphoproliferative disorders in a pediatric patient: a case report and literature review

Lianwei Ma
Xue Xing
Yonge Liu
Wei Jiang

doi 10.3389/fped.2025.1662074

965 views

CASE REPORT

Published on 30 Oct 2025

EBV-positive small cell neuroendocrine carcinoma of the nasopharynx with cervical lymph node metastasis: a case report and literature review

Jincai Xue
Wenjuan Ma
Xudong Liu
Yunsheng Wang
Xingyue Wang
Zhihu Li
Youxin Tian
Qinjiang Liu
Fang Dong

doi 10.3389/fonc.2025.1621859

771 views

ORIGINAL RESEARCH

Published on 02 Sep 2025

Co-expression of PD1+ and HLA-DR+ in CD8+ T cells is increased in tonsils of children with EBV primary and persistent infection

María Eugenia Amarillo
Karen Lindl
Veronica Lapido
Ignacio E. Rojas Campión
M. Soledad Collado
Johanna Speratti
Andrea Valerio
Plácida Baz
Elena De Matteo
1 more
Paola Chabay

doi 10.3389/fimmu.2025.1653165

1,405 views

CASE REPORT

Published on 31 Jul 2025

EBV-positive inflammatory follicular dendritic cell sarcoma occurring in different organs: a case report and literature review

Wenhua Bai
Chunfang Hu
Zheng Zhu

doi 10.3389/fonc.2025.1603496

1,270 views

ORIGINAL RESEARCH

Published on 29 Nov 2024

Entry into the lytic cycle exposes EBV-infected cells to NK cell killing via upregulation of the MICB ligand for NKG2D and activation of the CD56bright and NKG2A+KIR+CD56dim subsets

Maria Giovanna Desimio
Daniela Angela Covino
Caterina Cancrini
Margherita Doria

doi 10.3389/fimmu.2024.1467304

1,996 views
4 citations

REVIEW

Published on 09 Jul 2024

Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis

Manuel Ruiz-Pablos
Bruno Paiva
Aintzane Zabaleta

doi 10.3389/fimmu.2024.1422940

21,641 views
2 citations

REVIEW

Published on 07 Feb 2024

Epstein-Barr virus: the mastermind of immune chaos

Jean de Melo Silva
Carlos Eduardo de Castro Alves
Gemilson Soares Pontes

doi 10.3389/fimmu.2024.1297994

27,237 views
47 citations

REVIEW

Published on 21 Dec 2023

Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival

D. G. Sausen
M. C. Poirier
L. M. Spiers
E. N. Smith

doi 10.3389/fimmu.2023.1289313

4,764 views
22 citations

ORIGINAL RESEARCH

Published on 22 Jun 2023

Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas

Hannes Vietzen
Philipp B. Staber
Sarah M. Berger
Philippe L. Furlano
Laura M. Kühner
Simone Lubowitzki
Alexander Pichler
Robert Strassl
Jan J. Cornelissen
Elisabeth Puchhammer-Stöckl

doi 10.3389/fimmu.2023.1183788

3,175 views
12 citations

Share on

Frontiers in Immunology

Viral Immunology

Impact

70kTopic views
57kArticle views
11kArticle downloads

View impact

Articles

Hemophagocytic lymphohistiocytosis as the initial manifestation of Epstein–Barr virus-related T/NK-cell lymphoproliferative disorders in a pediatric patient: a case report and literature review

EBV-positive small cell neuroendocrine carcinoma of the nasopharynx with cervical lymph node metastasis: a case report and literature review

Co-expression of PD1+ and HLA-DR+ in CD8+ T cells is increased in tonsils of children with EBV primary and persistent infection

EBV-positive inflammatory follicular dendritic cell sarcoma occurring in different organs: a case report and literature review

Entry into the lytic cycle exposes EBV-infected cells to NK cell killing via upregulation of the MICB ligand for NKG2D and activation of the CD56bright and NKG2A+KIR+CD56dim subsets

Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis

Epstein-Barr virus: the mastermind of immune chaos

Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival

Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas

Frontiers in Immunology

Viral Immunology